Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia Areata is an autoimmune disease causing hair loss in patches, often starting before age 20, and while some cases recover on their own, treatments include topical corticosteroids, minoxidil, and promising new methods like IL-31 antibodies and 308-nm Excimer laser therapy.

Transplant success has improved with better immunosuppressive drugs and donor matching.

New targeted therapies for hair loss from alopecia areata show promise, with personalized treatment expected in the future.

Certain scalp tissue features can predict how well alopecia areata responds to steroid injections.

Adding antihistamines to topical corticosteroid and cryotherapy may improve hair regrowth in alopecia areata patients.

The conclusion is that understanding the complex relationship between allergies, autoimmunity, and psychological factors is key to treating skin disorders with itching.

Topical corticosteroids may be a safe and effective treatment for severe alopecia areata in children.

Corticosteroid injections helped eyebrow hair regrow in men with alopecia areata.

Biologic therapies can cause various adverse events, but allergy/immunology clinicians can manage them.

Both individual and combined treatments of tofacitinib and corticosteroids can help regrow hair in moderate-to-severe alopecia areata, but ongoing treatment may be necessary.

Using a strong allergy medicine too often on the scalp can cause swelling and inflammation.

Minoxidil can cause skin allergy; use alternative solvents or treatments if allergic.

Spironolactone in anti-acne cream can cause allergic skin reactions in some people.

A woman's severe skin reaction was caused by an allergy to a skin treatment.

Various drugs caused different skin reactions, including allergic and inflammatory responses.

Netherton Syndrome is a non-treatable genetic disorder in children causing skin, hair, and allergy issues.

The document concludes that proper diagnosis and evidence-based treatments are crucial for managing hair diseases, and psychological support for patients is important.

Calcipotriol works almost as well as clobetasol for mild to moderate alopecia areata with fewer side effects.

A woman's hair grew back after stopping acitretin for psoriasis and getting steroid treatment, and low vitamin D might be linked to alopecia severity.

Hair regrowth was seen in 83% of children with alopecia, immune system plays a role in the condition, and various treatments showed effectiveness for hair and nail disorders.

New effective scar treatments are urgently needed due to the current options' limited success.

Alopecia areata is likely caused by a combination of genetic factors and immune system dysfunction, and may represent different diseases with various causes.

New treatments for severe hair loss often fail, but some patients see hair regrowth with specific therapies, and treatment should be tailored to the individual's situation.

The document concludes that understanding and treating hair loss requires recognizing its various types and using appropriate diagnostic tools and treatments.

Most treatments for lichen planopilaris were found to be generally unsatisfactory.

Bee venom might be a good alternative treatment for various skin conditions because it has many healing properties.

The document concludes that treatment for cutaneous T-cell lymphoma should be customized to each patient's disease stage, balancing benefits and side effects, with no cure but many patients living long lives.

Hair loss in teenagers is hard to treat and lacks a cure, with some treatments available depending on the type of hair loss.

Some patients may experience temporary total hair loss from hepatitis C treatment with PEG-interferon and ribavirin.

A severe medication reaction required long treatment and led to hair loss and thyroid issues.